Latest news

Bioservo Technologies AB initiates research project to investigate the effect of using exoskeleton on the central nervous system

Rhino Tool House is revolutionizing manufacturing in the US with Ironhand 2.0

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

27 Sep, 2021  ·  Regulatory information

Madeleine Börjesson new CFO for Bioservo Technologies

Bioservo Technologies AB (publ) announces today that the company has contracted Madeleine Börjesson as new CFO and member of the management team. She succeeds Jacob Michlewics that has been interim CFO and takes office on 27 September 2021.

Madeleine has a bachelor's degree in business administration from the University of Gothenburg and has long and broad experience of leading international financial teams. Among other things, she has run change projects to structure and improve processes and routines at international companies within manufacturing industries.

The commercialization phase Bioservo is in with a strong focus on international expansion, we will greatly benefit from the broad experience Madeleine has from large multinational companies, says Petter Bäckgren, CEO of Bioservo.

 

For more information, please contact
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: 08 - 21 17 10
petter.backgren@bioservo.com

Note: This information is such as is required by Bioservo Technologies AB under the EU Market Abuse Regulation. The information was submitted, through the care of the above person, for publication on 27 September 2021 at 09:30 (CET).

 

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient.

The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength.

Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.

FNCA Sweden AB, +46(0)8-52800399, info@fnca.se is the company’s Certified Adviser on Nasdaq First North Growth Market.
For more information, please visit www.bioservo.com